We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTR
7126
DELISTED
CytRx Corp
CYTR
$6K ﹤0.01%
2,633
+1,122
+74% +$3.79K
IMDZ
7127
DELISTED
Immune Design Corp.
IMDZ
$6K ﹤0.01%
563
+128
+29% +$1.26K
SPLX
7128
DELISTED
ETRACS Monthly Reset 2xLeveraged S&P 500 total Return ETN
SPLX
$6K ﹤0.01%
+127
New +$5.79K
OREX
7129
DELISTED
Orexigen Therapeutics, Inc.
OREX
$6K ﹤0.01%
2,710
-2,419
-47% -$5.9K
ACHV icon
7130
Achieve Life Sciences
ACHV
$659M
$5K ﹤0.01%
+13
New +$9.33K
ACNB icon
7131
ACNB Corp
ACNB
$656M
$5K ﹤0.01%
190
+185
+3,700% +$5.15K
AFMD
7132
DELISTED
Affimed
AFMD
$5K ﹤0.01%
206
-80
-28% -$1.73K
BOTJ icon
7133
Bank Of The James
BOTJ
$123M
$5K ﹤0.01%
343
-727
-68% -$9.87K
CARZ icon
7134
First Trust Exchange-Traded Fund II First Trust S-Network Future Vehicles & Technology ETF
CARZ
$46M
$5K ﹤0.01%
136
-1,271
-90% -$48.4K
CASI
7135
DELISTED
CASI Pharmaceuticals
CASI
$5K ﹤0.01%
241
-519
-68% -$6.06K
CCRD
7136
DELISTED
CoreCard
CCRD
$5K ﹤0.01%
1,223
-498
-29% -$1.96K
MBAI
7137
Check-Cap
MBAI
$8.19M
$5K ﹤0.01%
11
-21
-66% -$9.12K
CMT icon
7138
Core Molding Technologies
CMT
$202M
$5K ﹤0.01%
+207
New +$4.35K
CPSS icon
7139
Consumer Portfolio Services
CPSS
$202M
$5K ﹤0.01%
1,095
-22,488
-95% -$95.6K
EMX
7140
DELISTED
EMX Royalty
EMX
$5K ﹤0.01%
+5,420
New +$5.09K
EMXC icon
7141
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.5B
$5K ﹤0.01%
+100
New +$5.12K
GEG icon
7142
Great Elm Group
GEG
$67.4M
$5K ﹤0.01%
1,177
-1,108
-48% -$3.8K
GEVO icon
7143
Gevo
GEVO
$360M
$5K ﹤0.01%
+366
New +$4.51K
HDMV icon
7144
First Trust Horizon Managed Volatility Developed International ETF
HDMV
$17.6M
$5K ﹤0.01%
156
-325
-68% -$10.8K
HYXF icon
7145
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$192M
$5K ﹤0.01%
+100
New +$5.21K
ICAD
7146
DELISTED
iCAD Inc
ICAD
$5K ﹤0.01%
1,111
-1,354
-55% -$5.18K
IPDN icon
7147
Professional Diversity Network
IPDN
$4.26M
$5K ﹤0.01%
62
-76
-55% -$7.89K
ISRA icon
7148
VanEck Israel ETF
ISRA
$152M
$5K ﹤0.01%
170
JAKK icon
7149
Jakks Pacific
JAKK
$301M
$5K ﹤0.01%
160
-497
-76% -$16.9K
LFVN icon
7150
LifeVantage
LFVN
$81.1M
$5K ﹤0.01%
1,072
-1,514
-59% -$5.93K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.